| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Kevin Bitterman is Director at EDIT, with reported holdings spanning 2 companies. From February 2016 to October 2026, the filings on record show 1 open-market purchase and 27 sales. Kevin Bitterman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.3M at current prices.
Our model assigns Kevin Bitterman a middling insider score of 61/100, based on 25 past trades. Over a 12-month horizon, 55.6% of those trades were profitable, with an average 12-month return of -0.3%.
Kevin Bitterman's largest disclosed position is in EDIT as Director, worth about $7.3M. The EDIT filings lean toward selling, a net 1,859,029 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 22, 2017 | EDIT Editas Medicine, Inc. | Director | Sell | 1,000,000 | $17.00 | $17,000,000.00 | -26.3% | |
| Dec 7, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 75,000 | $15.82 | $1,186,500.00 | -1.9% | |
| Dec 6, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 130,000 | $15.79 | $2,052,700.00 | -3.2% | |
| Nov 23, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 21,480 | $15.71 | $337,450.80 | -0.5% | |
| Nov 22, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 12,819 | $15.77 | $202,155.63 | -0.3% | |
| Nov 16, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 30,830 | $16.30 | $502,529.00 | -0.8% | |
| Nov 15, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 88,900 | $16.96 | $1,507,308.89 | -2.1% | |
| Sep 8, 2016 | EDIT Editas Medicine, Inc. | Director, 10% Owner | Sell | 500,000 | $16.80 | $8,400,000.00 | -10.7% |